{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T11:33:03Z","timestamp":1794396783172,"version":"4.9.0"},"reference-count":67,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T00:00:00Z","timestamp":1770854400000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"DOI":"10.1186\/s12913-025-13783-6","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T11:55:24Z","timestamp":1769169324000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antidiabetic prescribing patterns, quality, and economic influence in resource-limited settings: evidence from a Pakistani tertiary care hospital using WHO\/INRUD indicators"],"prefix":"10.1186","volume":"26","author":[{"given":"Amna","family":"Saeed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iltaf","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali Hassan","family":"Gillani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farhan","family":"Ullah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shafiq","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifra","family":"Maqbool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif Nawaz","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"1","key":"13783_CR1","doi-asserted-by":"publisher","first-page":"21908","DOI":"10.1038\/s41598-023-49249-0","volume":"13","author":"M Balooch Hasankhani","year":"2023","unstructured":"Balooch Hasankhani M, Mirzaei H, Karamoozian A. Global trend analysis of diabetes mellitus incidence, mortality, and mortality-to-incidence ratio from 1990 to 2019. Sci Rep. 2023;13(1):21908. https:\/\/doi.org\/10.1038\/s41598-023-49249-0.","journal-title":"Sci Rep"},{"issue":"1","key":"13783_CR2","doi-asserted-by":"publisher","first-page":"27","DOI":"10.24875\/RMU.19000130","volume":"22","author":"A Hassan-Gillani","year":"2020","unstructured":"Hassan-Gillani A, Saeed A, Khanum F, Uz-Zaman MQ, Akbar J. Evaluation of factors associated with medication adherence and hypertension among diabetic patients in Pakistan. Med Universitaria. 2020;22(1):27\u201337. https:\/\/doi.org\/10.24875\/RMU.19000130.","journal-title":"Med Universitaria"},{"key":"13783_CR3","doi-asserted-by":"publisher","unstructured":"Gillani AH, Bashir S, Ahmed AB, Usman M, Mustafa A, Iqbal T, et al. Macro and micro-vascular complications and their risk factors in diabetes mellitus patients of Southern Punjab, Pakistan. J Pharm Pract Community Med. 2018;4(2). https:\/\/doi.org\/10.5530\/jppcm.2018.2.17.","DOI":"10.5530\/jppcm.2018.2.17"},{"issue":"6","key":"13783_CR4","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1080\/14737167.2018.1503953","volume":"18","author":"AH Gillani","year":"2018","unstructured":"Gillani AH, Aziz MM, Masood I, Saqib A, Yang C, Chang J, et al. Direct and indirect cost of diabetes care among patients with type 2 diabetes in private clinics: a multicenter study in Punjab. Pakistan Expert Rev Pharmacoeconomics Outcomes Res. 2018;18(6):647\u201353.","journal-title":"Pakistan Expert Rev Pharmacoeconomics Outcomes Res"},{"key":"13783_CR5","unstructured":"Federation ID. IDF Diabetes Atlas 2025 2025 [Available from: https:\/\/diabetesatlas.org\/resources\/idf-diabetes-atlas-2025\/"},{"key":"13783_CR6","first-page":"40","volume":"2","author":"Y Hassan","year":"2009","unstructured":"Hassan Y, Mathialagan A, Awaisu A, Aziz N, Yahaya R, Salhani A. Trend in the use of oral hypoglycemic agents in an outpatient pharmacy department of a tertiary hospital in Malaysia (2003\u20132006). Asian J Pharm Clin Res. 2009;2:40\u20136.","journal-title":"Asian J Pharm Clin Res"},{"issue":"1","key":"13783_CR7","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.diabres.2011.02.035","volume":"93","author":"KM Hurren","year":"2011","unstructured":"Hurren KM, Taylor TN, Jaber LA. Antidiabetic prescribing trends and predictors of Thiazolidinedione discontinuation following the 2007 Rosiglitazone safety alert. Diabetes Res Clin Pract. 2011;93(1):49\u201355. https:\/\/doi.org\/10.1016\/j.diabres.2011.02.035.","journal-title":"Diabetes Res Clin Pract"},{"issue":"11","key":"13783_CR8","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1111\/dom.12101","volume":"15","author":"A Consoli","year":"2013","unstructured":"Consoli A, Formoso G. Do Thiazolidinediones still have a role in treatment of type 2 diabetes mellitus? Diabetes. Obes Metabolism. 2013;15(11):967\u201377. https:\/\/doi.org\/10.1111\/dom.12101.","journal-title":"Obes Metabolism"},{"issue":"19","key":"13783_CR9","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1001\/archinte.168.19.2088","volume":"168","author":"GC Alexander","year":"2008","unstructured":"Alexander GC, Sehgal NL, Moloney RM, Stafford RS. National trends in treatment of type 2 diabetes mellitus, 1994\u20132007. Arch Intern Med. 2008;168(19):2088\u201394.","journal-title":"Arch Intern Med"},{"issue":"5","key":"13783_CR10","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.2337\/dc13-2289","volume":"37","author":"C Hampp","year":"2014","unstructured":"Hampp C, Borders-Hemphill V, Moeny DG, Wysowski DK. Use of antidiabetic drugs in the US, 2003\u20132012. Diabetes Care. 2014;37(5):1367\u201374. https:\/\/doi.org\/10.2337\/dc13-2289.","journal-title":"Diabetes Care"},{"issue":"7","key":"13783_CR11","doi-asserted-by":"publisher","first-page":"e022768","DOI":"10.1136\/bmjopen-2018-022768","volume":"8","author":"S Wilkinson","year":"2018","unstructured":"Wilkinson S, Douglas I, Stirnadel-Farrant H, Fogarty D, Pokrajac A, Smeeth L, et al. Changing use of antidiabetic drugs in the UK: trends in prescribing 2000\u20132017. BMJ Open. 2018;8(7):e022768.","journal-title":"BMJ Open"},{"key":"13783_CR12","doi-asserted-by":"publisher","DOI":"10.3399\/bjgp20X714089","author":"M Greiver","year":"2020","unstructured":"Greiver M, Havard A, Bowles JK, Kalia S, Chen T, Aliarzadeh B, et al. Trends in diabetes medication use in Australia, Canada, England, and scotland: a repeated cross-sectional analysis in primary care. Br J Gen Pract. 2020. https:\/\/doi.org\/10.3399\/bjgp20X714089.","journal-title":"Br J Gen Pract"},{"key":"13783_CR13","doi-asserted-by":"publisher","first-page":"15","DOI":"10.13040\/IJPSR.0975-8232.9(8).3487-92","volume":"10","author":"P Bhavana","year":"2018","unstructured":"Bhavana P, Kumar VS, Divya N, Pratheek KP, Rao GE. Assessment of the prescription pattern of oral hypoglycemic drugs in uncomplicated diabetes mellitus patients at tertiary care hospital. Environments. 2018;10:15. https:\/\/doi.org\/10.13040\/IJPSR.0975-8232.9(8).3487-92.","journal-title":"Environments"},{"issue":"4","key":"13783_CR14","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1515\/jbcpp-2012-0012","volume":"23","author":"A Khalam","year":"2012","unstructured":"Khalam A, Dilip C, Shinu C. Drug use evaluation of diabetes mellitus in hospitalized patients of a tertiary care referral hospital. J Basic Clin Physiol Pharmacol. 2012;23(4):173\u20137. https:\/\/doi.org\/10.1515\/jbcpp-2012-0012.","journal-title":"J Basic Clin Physiol Pharmacol"},{"issue":"4","key":"13783_CR15","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/jphs.12376","volume":"11","author":"DH Abdel-Qader","year":"2020","unstructured":"Abdel-Qader DH, Al Meslamani AZ, El-Shara\u2019 AA, Ismael NS, Albassam A, Lewis PJ, et al. Investigating prescribing errors in the emergency department of a large governmental hospital in Jordan. J Pharm Health Serv Res. 2020;11(4):375\u201382. https:\/\/doi.org\/10.1111\/jphs.12376.","journal-title":"J Pharm Health Serv Res"},{"issue":"5","key":"13783_CR16","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/dme.12894","volume":"33","author":"F Formiga","year":"2016","unstructured":"Formiga F, Vidal X, Agust\u00ed A, Chivite D, Ros\u00f3n B, Barb\u00e9 J, et al. Inappropriate prescribing in elderly people with diabetes admitted to hospital. Diabet Med. 2016;33(5):655\u201362. https:\/\/doi.org\/10.1111\/dme.12894.","journal-title":"Diabet Med"},{"key":"13783_CR17","unstructured":"Organization WH. WHO calls for urgent action by countries for achieving Medication Without Harm 2022 [Available from: https:\/\/www.who.int\/news\/item\/16-09-2022-who-calls-for-urgent-action-by-countries-for-achieving-medication-without-harm"},{"issue":"4","key":"13783_CR18","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1007\/s11096-022-01414-7","volume":"44","author":"MB Ayalew","year":"2022","unstructured":"Ayalew MB, Spark MJ, Quirk F, Dieberg G. Potentially inappropriate prescribing for adults living with diabetes mellitus: a scoping review. Int J Clin Pharm. 2022;44(4):860\u201372.","journal-title":"Int J Clin Pharm"},{"issue":"243","key":"13783_CR19","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.31729\/jnma.7080","volume":"59","author":"LR Tuladhar","year":"2021","unstructured":"Tuladhar LR, Shrestha SL, Regmi D, Bimali S, Bhusal S, Khadka P. Drug-drug interactions between hypoglycemic and non-hypoglycemic medication in diabetic patients with comorbidities in a tertiary care center: a descriptive cross-sectional study. JNMA: J Nepal Med Association. 2021;59(243):1125. https:\/\/doi.org\/10.31729\/jnma.7080.","journal-title":"JNMA: J Nepal Med Association"},{"key":"13783_CR20","first-page":"1","volume-title":"Global burden of diabetes mellitus","author":"P Arokiasamy","year":"2021","unstructured":"Arokiasamy P, Salvi S, Selvamani Y. Global burden of diabetes mellitus. Handbook of global health: Springer; 2021. pp. 1\u201344."},{"issue":"1","key":"13783_CR21","doi-asserted-by":"publisher","first-page":"23037","DOI":"10.1038\/s41598-023-50517-2","volume":"13","author":"MD Butt","year":"2023","unstructured":"Butt MD, Ong SC, Rafiq A, Malik T, Sajjad A, Batool N, et al. An observational multi-center study on type 2 diabetes treatment prescribing pattern and patient adherence to treatment. Sci Rep. 2023;13(1):23037. https:\/\/doi.org\/10.1038\/s41598-023-50517-2.","journal-title":"Sci Rep"},{"issue":"1","key":"13783_CR22","doi-asserted-by":"publisher","first-page":"2519140","DOI":"10.53350\/pjmhs22168902","volume":"18","author":"AA Mahmoud","year":"2025","unstructured":"Mahmoud AA, Elnour AA, Saeed AA, Menon V, Elhag SA, Fathi GO, et al. Comparative assessment of rational use of drugs in public and private hospital pharmacies: a multicenter cross-sectional study using INRUD\/WHO prescribing indicators. J Pharm Policy Pract. 2025;18(1):2519140. https:\/\/doi.org\/10.53350\/pjmhs22168902.","journal-title":"J Pharm Policy Pract"},{"issue":"1","key":"13783_CR23","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1093\/jphsr\/rmac057","volume":"14","author":"J Ur Rahman","year":"2023","unstructured":"Ur Rahman J, Ahmad T, Khan M, Ur Rahman A, Ghani S, Ullah Khan F. Assessment of prescribing patterns and medication errors related to prescriptions in hospitalized diabetes mellitus type-2 patients in Khyber Pakhtunkhwa, Pakistan. J Pharm Health Serv Res. 2023;14(1):49\u201354. https:\/\/doi.org\/10.1093\/jphsr\/rmac057.","journal-title":"J Pharm Health Serv Res"},{"key":"13783_CR24","unstructured":"Organization WH. Promoting rational use of medicines: core components 2002 [Available from: https:\/\/iris.who.int\/handle\/10665\/67438"},{"issue":"2","key":"13783_CR25","doi-asserted-by":"publisher","first-page":"76","DOI":"10.3390\/pharmacy9020076","volume":"9","author":"SF Zaidi","year":"2021","unstructured":"Zaidi SF, Mgarry R, Alsanea A, Almutairi SK, Alsinnari Y, Alsobaei S, et al. A questionnaire-based survey to assess the level of knowledge and awareness about drug\u2013food interactions among general public in Western Saudi Arabia. Pharmacy. 2021;9(2):76. https:\/\/doi.org\/10.3390\/pharmacy9020076.","journal-title":"Pharmacy"},{"key":"13783_CR26","doi-asserted-by":"publisher","unstructured":"Goruntla N, Ssesanga J, Bommireddy BR, Thammisetty DP, Kasturi Vishwanathasetty V, Ezeonwumelu JOC et al. Evaluation of rational drug use based on who\/inrud core drug use indicators in a secondary care hospital: a cross-sectional study in western Uganda. Drug, Healthcare and Patient Safety. 2023:125\u2009\u2013\u200935. https:\/\/doi.org\/10.2147\/DHPS.S424050","DOI":"10.2147\/DHPS.S424050"},{"issue":"4","key":"13783_CR27","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1093\/jphsr\/rmac048","volume":"13","author":"R Abu Farha","year":"2022","unstructured":"Abu Farha R, Awwad O, Abdurazaq B, Abu Hammour K, Akour A. Evaluation of drug use pattern in adults\u2019 outpatient clinics in a tertiary teaching hospital using WHO core prescribing indicators. J Pharm Health Serv Res. 2022;13(4):357\u201363.","journal-title":"J Pharm Health Serv Res"},{"issue":"7","key":"13783_CR28","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1080\/23744235.2020.1753887","volume":"52","author":"ZU Mustafa","year":"2020","unstructured":"Mustafa ZU, Salman M, Rao AZ, Asif N, Butt SA, Shehzadi N, et al. Assessment of antibiotics use for children upper respiratory tract infections: a retrospective, cross-sectional study from Pakistan. Infect Dis. 2020;52(7):473\u20138.","journal-title":"Infect Dis"},{"key":"13783_CR29","unstructured":"Organization WH. WHO Model List of Essential Medicines \u2013\u200923rd list 2023 [Available from: https:\/\/www.who.int\/publications\/i\/item\/WHO-MHP-HPS-EML-2023.02"},{"key":"13783_CR30","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12913-016-1932-2","volume":"16","author":"M Atif","year":"2016","unstructured":"Atif M, Sarwar MR, Azeem M, Naz M, Amir S, Nazir K. Assessment of core drug use indicators using WHO\/INRUD methodology at primary healthcare centers in Bahawalpur, Pakistan. BMC Health Serv Res. 2016;16:1\u20139. https:\/\/doi.org\/10.1186\/s12913-016-1932-2.","journal-title":"BMC Health Serv Res"},{"key":"13783_CR31","doi-asserted-by":"publisher","unstructured":"Nyabuti AO, Okalebo FA, Guantai EM. Examination of WHO\/INRUD core drug use indicators at public primary healthcare centers in Kisii County, Kenya. Advances in Pharmacological and pharmaceutical sciences. 2020;2020(1):3173847. https:\/\/doi.org\/10.1155\/2020\/3173847","DOI":"10.1155\/2020\/3173847"},{"key":"13783_CR32","unstructured":"Pakistan DRAo. National Essential Medicines List 2023 [Available from: https:\/\/www.dra.gov.pk\/publications\/national-essential-medicine-lists\/"},{"issue":"1","key":"13783_CR33","doi-asserted-by":"publisher","first-page":"2519140","DOI":"10.1080\/20523211.2025.2519140","volume":"18","author":"AA Mahmoud","year":"2025","unstructured":"Mahmoud AA, Elnour AA, Saeed AA, Menon V, Elhag SA, Fathi GO, et al. Comparative assessment of rational use of drugs in public and private hospital pharmacies: a multicenter cross-sectional study using INRUD\/WHO prescribing indicators. J Pharm Policy Pract. 2025;18(1):2519140. https:\/\/doi.org\/10.1080\/20523211.2025.2519140.","journal-title":"J Pharm Policy Pract"},{"issue":"10","key":"13783_CR34","doi-asserted-by":"publisher","first-page":"e0285171","DOI":"10.1371\/journal.pone.0285171","volume":"18","author":"M Ali","year":"2023","unstructured":"Ali M, Shoaib MH, Nesar S, Akhtar H, Shahnaz S, Khan Q, et al. Assessment of potential drug-related problems (PDRP) and clinical outcomes in bacterial meningitis patients admitted to tertiary care hospitals. PLoS ONE. 2023;18(10):e0285171. https:\/\/doi.org\/10.1371\/journal.pone.0285171.","journal-title":"PLoS ONE"},{"issue":"1","key":"13783_CR35","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s40545-023-00607-3","volume":"16","author":"YK Anagaw","year":"2023","unstructured":"Anagaw YK, Limenh LW, Geremew DT, Worku MC, Dessie MG, Tessema TA, et al. Assessment of prescription completeness and drug use pattern using WHO prescribing indicators in private community pharmacies in addis ababa: a cross-sectional study. J Pharm Policy Pract. 2023;16(1):124. https:\/\/doi.org\/10.1186\/s40545-023-00607-3.","journal-title":"J Pharm Policy Pract"},{"key":"13783_CR36","unstructured":"Organization WH. Using indicators to measure country pharmaceutical situations: fact book on WHO level I and level II monitoring indicators 2006 [Available from: https:\/\/iris.who.int\/handle\/10665\/354554"},{"issue":"5","key":"13783_CR37","first-page":"851","volume":"12","author":"AM Samtia","year":"2013","unstructured":"Samtia AM, Rasool MF, Ranjha NM, Usman F, Javed I. A multifactorial intervention to enhance adherence to medications and disease-related knowledge in type 2 diabetic patients in Southern Punjab, Pakistan. Trop J Pharm Res. 2013;12(5):851\u20136.","journal-title":"Trop J Pharm Res"},{"issue":"2","key":"13783_CR38","doi-asserted-by":"publisher","first-page":"e025300","DOI":"10.1136\/bmjopen-2018-025300","volume":"9","author":"AH Aamir","year":"2019","unstructured":"Aamir AH, Ul-Haq Z, Mahar SA, Qureshi FM, Ahmad I, Jawa A, et al. Diabetes prevalence survey of Pakistan (DPS-PAK): prevalence of type 2 diabetes mellitus and prediabetes using HbA1c: a population-based survey from Pakistan. BMJ Open. 2019;9(2):e025300. https:\/\/doi.org\/10.1136\/bmjopen-2018-025300.","journal-title":"BMJ Open"},{"issue":"4","key":"13783_CR39","doi-asserted-by":"publisher","first-page":"1173","DOI":"10.12669\/pjms.35.4.194","volume":"35","author":"S Akhtar","year":"2019","unstructured":"Akhtar S, Nasir JA, Abbas T, Sarwar A. Diabetes in pakistan: A systematic review and meta-analysis. Pakistan J Med Sci. 2019;35(4):1173. https:\/\/doi.org\/10.12669\/pjms.35.4.194.","journal-title":"Pakistan J Med Sci"},{"issue":"8","key":"13783_CR40","doi-asserted-by":"publisher","first-page":"e0289502","DOI":"10.1371\/journal.pone.0289502","volume":"18","author":"S Shah","year":"2023","unstructured":"Shah S, Abbas G, Aslam A, Randhawa FA, Khan FU, Khurram H, et al. Assessment of health-related quality of life among patients with obesity, hypertension and type 2 diabetes mellitus and its relationship with Multimorbidity. PLoS ONE. 2023;18(8):e0289502. https:\/\/doi.org\/10.1371\/journal.pone.0289502.","journal-title":"PLoS ONE"},{"key":"13783_CR41","doi-asserted-by":"publisher","first-page":"162","DOI":"10.18203\/2394-6040.ijcmph20210228","volume":"1","author":"K Kumar","year":"2013","unstructured":"Kumar K, Sreeramya G, Krishna K, Nalini K, Kiranmai N, Vasavi P. Drug use pattern study of antidiabetics in type 2 diabetes mellitus at a tertiary care hospital in Tenali, Andhra Pradesh. Int J Inv Pharm Sci. 2013;1:162\u20136. https:\/\/doi.org\/10.18203\/2394-6040.ijcmph20210228.","journal-title":"Int J Inv Pharm Sci"},{"issue":"5, Part B","key":"13783_CR42","first-page":"76","volume":"4","author":"G Ramachandran","year":"2015","unstructured":"Ramachandran G, Rohith V, Topno I. Evaluation of prescribing pattern of anti-diabetic drugs using WHO prescribing indicators in a tertiary care hospital in puducherry: A cross-sectional study. Pharma Innov. 2015;4(5, Part B):76.","journal-title":"Pharma Innov"},{"issue":"1","key":"13783_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.4103\/2230-8210.131767","volume":"19","author":"O Akhter","year":"2015","unstructured":"Akhter O, Fiazuddin F, Shaheryar A, Niaz W, Siddiqui D, Awan S, et al. Central adiposity is significantly higher in female compared to male in Pakistani type 2 diabetes mellitus patients. Indian J Endocrinol Metabol. 2015;19(1):72\u20136. https:\/\/doi.org\/10.4103\/2230-8210.131767.","journal-title":"Indian J Endocrinol Metabol"},{"key":"13783_CR44","doi-asserted-by":"publisher","unstructured":"Saher T, Al-Worafi YM, Iqbal MN, Wahid A, Iqbal Q, Khan A, Ahmed I, Raja UY, Wahab MU, Rehman T, Ishtiaq O, Aamir A, et al. Doctors\u2019 adherence to guidelines recommendations and glycaemic control in diabetic patients in Quetta, Pakistan: Findings from an observational study. Front MedicineBMC Endocr Disorders. 20222022;9(1):978345. https:\/\/doi.org\/10.3389\/fmed.2022.97834545.","DOI":"10.3389\/fmed.2022.97834545"},{"key":"13783_CR45","doi-asserted-by":"crossref","unstructured":"Ahmed I, Raja UY, Wahab MU, Rehman T, Ishtiaq O, Aamir A, et al. Efficacy and safety of combination of empagliflozin and metformin with combination of sitagliptin and metformin during Ramadan: an observational study. BMC Endocrine Disorders. 2022;22(1):247. doi: 10.1186\/s12902-022-01168-3","DOI":"10.1186\/s12902-022-01168-3"},{"key":"13783_CR46","doi-asserted-by":"publisher","unstructured":"Zakaraia H, Salem H, Mostafa M, Ali A, Rabea H. Adding empagliflozin to sitagliptin plus Metformin vs. adding sitagliptin to empagliflozin plus Metformin as triple therapy in Egyptian patients with type 2 diabetes: a 12-week open trial. Eur Rev Med Pharmacol Sci. 2023;27(15). https:\/\/doi.org\/10.26355\/eurrev_202308_33300.","DOI":"10.26355\/eurrev_202308_33300"},{"key":"13783_CR47","doi-asserted-by":"publisher","first-page":"253","DOI":"10.4093\/dmj.2023.0128","volume":"48","author":"Y-H Park","year":"2024","unstructured":"Park Y-H, Sohn M, Lee SY, Lim S. Two-year therapeutic efficacy and safety of initial triple combination of metformin, sitagliptin, and empagliflozin in drug-na\u00efve type 2 diabetes mellitus patients. Diabetes Metab J. 2024;48:253\u201364. https:\/\/doi.org\/10.4093\/dmj.2023.0128.","journal-title":"Diabetes Metab J"},{"issue":"9","key":"13783_CR48","doi-asserted-by":"publisher","first-page":"e44709","DOI":"10.7759\/cureus.44709","volume":"15","author":"M Ahmed","year":"2023","unstructured":"Ahmed M, Saeed A, Khan MZ, Javaid SZ, Aslam F, Dar SI. A comparison of the effects of empagliflozin and sitagliptin, when combined with metformin, on lipid levels in patients with type 2 diabetes: a clinical investigation. Cureus. 2023;15(9):e44709. https:\/\/doi.org\/10.7759\/cureus.44709.","journal-title":"Cureus"},{"issue":"3","key":"13783_CR49","doi-asserted-by":"publisher","first-page":"349","DOI":"10.2165\/11206060-000000000-00000","volume":"71","author":"CM Chwieduk","year":"2011","unstructured":"Chwieduk CM. Sitagliptin\/metformin fixed-dose combination: in patients with type 2 diabetes mellitus. Drugs. 2011;71(3):349\u201361.","journal-title":"Drugs"},{"key":"13783_CR50","doi-asserted-by":"publisher","first-page":"14","DOI":"10.2337\/cd17-0119","volume":"36","author":"CARE I","year":"2018","unstructured":"CARE I. Standards of medical care in diabetes\u20142018 abridged for primary care providers. Clin Diabetes. 2018;36:14\u201337.","journal-title":"Clin Diabetes"},{"issue":"4","key":"13783_CR51","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1177\/1932296816633721","volume":"10","author":"P Lasalvia","year":"2016","unstructured":"Lasalvia P, Barahona-Correa JE, Romero-Alvernia DM, Gil-Tamayo S, Casta\u00f1eda-Cardona C, Bayona JG, et al. Pen devices for insulin self-administration compared with needle and vial: systematic review of the literature and meta-analysis. J Diabetes Sci Technol. 2016;10(4):959\u201366. https:\/\/doi.org\/10.1177\/1932296816633721.","journal-title":"J Diabetes Sci Technol"},{"issue":"02","key":"13783_CR52","doi-asserted-by":"publisher","first-page":"074","DOI":"10.1055\/s-0045-1802356","volume":"8","author":"S Abbas","year":"2025","unstructured":"Abbas S, Javed A, Khalid M, Talha SM, Zainab P, Bibi A, et al. A comparative evaluation of insulin syringe and prefilled pen usability and preference among the population with diabetes in Pakistan. J Diabetes Endocr Pract. 2025;8(02):074\u20139. https:\/\/doi.org\/10.1055\/s-0045-1802356.","journal-title":"J Diabetes Endocr Pract"},{"issue":"9","key":"13783_CR53","doi-asserted-by":"publisher","first-page":"1969","DOI":"10.1007\/s40520-022-02165-1","volume":"34","author":"F Remelli","year":"2022","unstructured":"Remelli F, Ceresini MG, Trevisan C, Noale M, Volpato S. Prevalence and impact of polypharmacy in older patients with type 2 diabetes. Aging Clin Exp Res. 2022;34(9):1969\u201383.","journal-title":"Aging Clin Exp Res"},{"key":"13783_CR54","doi-asserted-by":"publisher","unstructured":"Brar MS, Gupta M, Gupta VK, Garg K, Kaur AN. Prescription patterns of oral antidiabetic agents in management of T2DM by Doctors in Punjab. Int J Diabetes Developing Ctries. 2024:1\u20137. https:\/\/doi.org\/10.1007\/s13410-024-01425-2","DOI":"10.1007\/s13410-024-01425-2"},{"issue":"1","key":"13783_CR55","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1186\/s40545-022-00501-4","volume":"15","author":"HA Merchant","year":"2022","unstructured":"Merchant HA, Babar Z-U-D, Hussain IM. A leap towards enforcing medicines prescribing by generic names in low-and middle-income countries (LMICs): pitfalls, limitations, and recommendations for local drug regulatory agencies. J Pharm Policy Pract. 2022;15(1):104. https:\/\/doi.org\/10.1186\/s40545-022-00501-4.","journal-title":"J Pharm Policy Pract"},{"key":"13783_CR56","doi-asserted-by":"publisher","first-page":"1627735","DOI":"10.3389\/fphar.2025.1627735","volume":"16","author":"A Saeed","year":"2025","unstructured":"Saeed A, Shukar S, Yasin NA, Yang C, Jiang M, Aziz MM, et al. Pakistan\u2019s first medicine price deregulation policy: assessing its impact on Prices, Affordability, and availability of oral Anti-Diabetic medicines in private pharmacies. Front Pharmacol. 2025;16:1627735.","journal-title":"Front Pharmacol"},{"key":"13783_CR57","doi-asserted-by":"publisher","first-page":"820621","DOI":"10.3389\/fphar.2025.1627735","volume":"13","author":"A Saeed","year":"2022","unstructured":"Saeed A, Lambojon K, Saeed H, Saleem Z, Anwer N, Aziz MM, et al. Access to insulin products in pakistan: A National scale cross-sectional survey on prices, availability, and affordability. Front Pharmacol. 2022;13:820621. https:\/\/doi.org\/10.3389\/fphar.2025.1627735.","journal-title":"Front Pharmacol"},{"issue":"4","key":"13783_CR58","first-page":"102","volume":"4","author":"MK Saurabh","year":"2011","unstructured":"Saurabh MK, Biswas NK, Yadav AK, Singhai A, Saurabh A. Study of prescribing habits and assessment of rational use of drugs among Doctors of primary health care facilities. Asian J Pharm Clin Res. 2011;4(4):102\u20135.","journal-title":"Asian J Pharm Clin Res"},{"issue":"3","key":"13783_CR59","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s11096-013-9764-1","volume":"35","author":"M Ismail","year":"2013","unstructured":"Ismail M, Iqbal Z, Khattak MB, Khan MI, Arsalan H, Javaid A, et al. Potential drug\u2013drug interactions in internal medicine wards in hospital setting in Pakistan. Int J Clin Pharm. 2013;35(3):455\u201362. https:\/\/doi.org\/10.1007\/s11096-013-9764-1.","journal-title":"Int J Clin Pharm"},{"issue":"1","key":"13783_CR60","doi-asserted-by":"publisher","first-page":"144","DOI":"10.12669\/pjms.341.13986","volume":"34","author":"R Farooqui","year":"2018","unstructured":"Farooqui R, Hoor T, Karim N, Muneer M. Potential drug-drug interactions among patients prescriptions collected from medicine out-patient setting. Pakistan J Med Sci. 2018;34(1):144. https:\/\/doi.org\/10.12669\/pjms.341.13986.","journal-title":"Pakistan J Med Sci"},{"issue":"4","key":"13783_CR61","first-page":"93","volume":"3","author":"V Sankar","year":"2015","unstructured":"Sankar V, Saaed Y, Joseph RM, Azizi H, Mariyam Thomas P. Serious drug-drug interactions in the prescriptions of diabetic patients. Med Sci. 2015;3(4):93\u2013103.","journal-title":"Med Sci"},{"issue":"3","key":"13783_CR62","doi-asserted-by":"publisher","first-page":"238","DOI":"10.3126\/kumj.v7i3.2730","volume":"7","author":"M Ansari","year":"2009","unstructured":"Ansari M, Neupane D. Study on determination of errors in prescription writing: A semi-electronic perspective. Kathmandu Univ Med J. 2009;7(3):238\u201341. https:\/\/doi.org\/10.3126\/kumj.v7i3.2730.","journal-title":"Kathmandu Univ Med J"},{"issue":"8","key":"13783_CR63","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1111\/dme.13982","volume":"36","author":"A Bain","year":"2019","unstructured":"Bain A, Hasan S, Babar Z-U-D. Interventions to improve insulin prescribing practice for people with diabetes in hospital: a systematic review. Diabet Med. 2019;36(8):948\u201360. https:\/\/doi.org\/10.1111\/dme.13982.","journal-title":"Diabet Med"},{"issue":"5","key":"13783_CR64","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.4314\/tjpr.v18i5.29","volume":"18","author":"SM Alshahrani","year":"2019","unstructured":"Alshahrani SM, Alakhali KM, Al-Worafi YM. Medication errors in a health care facility in Southern Saudi Arabia. Trop J Pharm Res. 2019;18(5):1119\u201322. https:\/\/doi.org\/10.4314\/tjpr.v18i5.29.","journal-title":"Trop J Pharm Res"},{"key":"13783_CR65","unstructured":"Bank TW. Poverty and Inequality 2023 [Available from: https:\/\/datatopics.worldbank.org\/world-development-indicators\/themes\/poverty-and-inequality.html"},{"key":"13783_CR66","unstructured":"Kundi IA. Federal govt notifies minimum wage rate at Rs32,000 per month: The Nation; 2023 [Available from: https:\/\/www.nation.com.pk\/08-Nov-2023\/federal-govt-notifies-minimum-wage-rate-at-rs32-000-per-month"},{"issue":"10","key":"13783_CR67","doi-asserted-by":"publisher","first-page":"e034720","DOI":"10.1136\/bmjopen-2019-034720","volume":"10","author":"A Saeed","year":"2020","unstructured":"Saeed A, Saeed H, Saleem Z, Yang C, Jiang M, Zhao M, et al. Impact of National drug pricing policy 2018 on access to medicines in Lahore division, pakistan: a pre-post survey study using WHO\/HAI methodology. BMJ Open. 2020;10(10):e034720. https:\/\/doi.org\/10.1136\/bmjopen-2019-034720.","journal-title":"BMJ Open"}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-025-13783-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-025-13783-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,12]],"date-time":"2026-02-12T08:59:24Z","timestamp":1770886764000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12913-025-13783-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":67,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13783"],"URL":"https:\/\/doi.org\/10.1186\/s12913-025-13783-6","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"19 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The current study was conducted in accordance with the Declaration of Helsinki and was also approved by the Institutional Medical and Ethics review committee of Ayub Medical Teaching Institution, Abbottabad, Pakistan (Approval Code\/Ref.No.RC-EA-2024\/166, Dated: August 20, 2024). Informed consent to participate was obtained from all of the participants in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"230"}}